NYSCF Principal Scientist Josephine (Josi) Wesely, PhD, was probably the only kid who showed up to her doctor’s appointments with scientific papers in hand. “I was...
As NYSCF enters 2023, we’re taking a moment to look back at the defining moments of 2022. Whether it was gathering in person again for our...
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
This November, National Diabetes Month yielded some early holiday cheer as the FDA approved an exciting preventative treatment for type 1 diabetes (T1D). This work was...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
“My colleagues and I are delighted to bring the NYSCF lab to you here at SNF Nostos Health today, and to show you in real time...
Alzheimer’s, Parkinson’s, multiple sclerosis, cancer: they’re all diseases that are, to this day, largely a mystery, and treatment options are scarce. But thanks to stem cells,...
2021 has been a banner year for science. With your support, we opened a new laboratory for creating clinical-grade cells to treat blindness, created stem cell...
On October 19th and 20th, we hosted the sixteenth annual NYSCF Conference on translational stem cell research. This year’s meeting, held virtually for the second consecutive...
Annually for the past 15 years, the NYSCF Conference has showcased the latest cutting-edge findings in translational stem cell research, gathering world-renowned multi-disciplinary speakers and 500+...
NYSCF Board Member Kay Unger may be best known for her eponymous brand and trailblazing career in fashion, but she’s also an inspiring advocate for biomedical...
“My oldest son, Andrew, is a cancer survivor,” said Tony Coles, MD, PhD, CEO of Cerevel Therapeutics. “He was afflicted with non-Hodgkins lymphoma when he...
Hosted by CNN’s Chief Medical Correspondent Sanjay Gupta, MD, this year’s New York Stem Cell Foundation Research Institute Gala & Science Fair went virtual for the...
The Context: Organoids – 3D structures of human tissue derived from stem cells – are a critical tool for helping researchers study diseases like cancer and...
“How many people were promised a cure [for type 1 diabetes] within five or ten years?” JDRF CEO Aaron Kowalski asks the audience. Half the hands...
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
In 2006, Shinya Yamanaka, MD, PhD, made a discovery that revolutionized biomedical research and earned him a Nobel Prize. His lab found that stem cells, the...
“I got involved in type one diabetes advocacy over 25 years ago when my son was diagnosed,” said NYSCF CEO Susan L. Solomon, JD. “At that...
“Medicine shouldn’t be one size fits all,” National Institutes of Health (NIH) Director Dr. Francis Collins told the audience of the NYSCF Conference last week. “Think...
Lyfebulb, a patient-empowerment platform that connects chronic disease patients, industry, and investors to empower patients and support user-driven innovation, and The New York Stem Cell Foundation...
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Leaders in stem cell biology and researchers at the forefront of translational medicine convened at the 2016 NYSCF Conference to discuss the latest advances in using...
NYSCF – Robertson Investigator Alumna Dr. Shuibing Chen published her latest work in Cell Stem Cell creating stem cell models of type 2 diabetes in a...
Normal human cells contain two copies of each gene – one inherited from a mother, and one from a father. An international collaboration of scientists including...
